Latest News and Press Releases

LEIDEN, Netherlands, Nov. 16, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) presented a comprehensive update on the Company's in-house and partnered product development programs...

LEIDEN, The Netherlands, Nov. 12, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and the International AIDS Vaccine Initiative (IAVI) announced today that...

LEIDEN, Netherlands, Nov. 10, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and the Netherlands Vaccine Institute (NVI) announced today that they have...

LEIDEN, The Netherlands and MECHELEN, Belgium, Nov. 9, 2004 (PRIMEZONE) -- Galapagos Genomics announced today that it has reached a research milestone in its osteoporosis discovery program with Wyeth...

LEIDEN, Netherlands, Nov. 05, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext, Nasdaq:CRXL), invites investors, the media and the general public to view a live video webcast of its Analyst Day Meeting at...

LEIDEN, Netherlands, Oct. 20, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced its Chief Financial Officer, Leonard Kruimer, will present at the Rodman & Renshaw...

LEIDEN, Netherlands and DULUTH, Ga., Oct. 18, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and Merial, a world-leading animal health company, today...

LEIDEN, The Netherlands, Oct. 12, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) today announced its financial results for the third quarter of 2004. Crucell...

LEIDEN, The Netherlands, Oct. 7, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has initiated legal proceedings in the District...

LEIDEN, The Netherlands, Oct. 6, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted two patents by the European patent...